European Journal of Clinical Pharmacology

, Volume 32, Issue 4, pp 335–338 | Cite as

Magnesium depletion in patients on long-term chlorthalidone therapy for essential hypertension

  • G. Cocco
  • H. U. Iselin
  • C. Strozzi
  • B. Cesana
  • H. R. Baumeler
Originals

Summary

Sixty patients were treated for 1 year for essential uncomplicated hypertension, 30 with beta-blockers alone (BB) and 30 with BB and chlorthalidone (CTD). BB did not affect serum K+ or Mg++. In the BB-group there was a statistically significant trend towards retention of Mg++ in a loading test, but the effect was clinically marginal. BB + CTD reduced serum K+ and Mg++ and caused significant Mg++ depletion, as shown by the Mg++ loading test. All the effects were highly significant and were clinically important. The metabolic perturbations due to CTD are potentially dangerous and make this drug unattractive as ‘first choice’ treatment for hypertension.

Key words

chlorthalidone magnesium depletion hypertension adverse effect 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Günther T (1981) Biochemistry and pathobiochemistry of magnesium. 3rd Internat. Symp. on Magnesium. Baden-Baden 1981, Magnesium Bulletin 3: 91–101Google Scholar
  2. 2.
    Altura BMA, Altura BT (1984) Magnesium, electrolyte transport and coronary vascular tone. Drugs 28 [Suppl] 1: 120–142Google Scholar
  3. 3.
    Leary WP, Reyes AJ (1984) Diuretic-induced magnesium losses. Drugs 28 [Suppl 1]: 143–150Google Scholar
  4. 4.
    Ross EJ (1975) Aldosterone and aldosteronism. Lloyd-Luke, London, pp 93–113Google Scholar
  5. 5.
    Swales JD (1982) Magnesium deficiency and diuretics. Br Med J 285: 1377–1378Google Scholar
  6. 6.
    Dyckner T, Wester PO, Widman L (1981) Potassium- and magnesiumsparing diuretics: Effects on skeletal muscle electrolytes. 3rd Internat. Symp. on Magnesium. Baden-Baden 1981, Magnesium Bulletin 3: 105–109Google Scholar
  7. 7.
    Duarte CG (1968) Effects of ethacrinic and frusemide on urinary calcium, phosphate and magnesium. Metabolism 17: 867–876Google Scholar
  8. 8.
    Lim P, Jacob E (1972) Magnesium deficiency in patients on long-term diuretic therapy for heart failure. Br Med J 3: 620–622Google Scholar
  9. 9.
    Whang R (1984) Magnesium deficiency. Causes and implications. Drugs 28 [Suppl 1]: 143–150Google Scholar
  10. 10.
    Wester PO, Dyckner T (1981) The role of magnesium in repletion of potassium. 3rd Internat. Symp. on Magnesium. Baden-Baden 1981, Magnesium Bull 3: 91–103Google Scholar
  11. 11.
    Altura BMA, Altura BT (1983) Magnesium-calcium interaction and contraction of arterial smooth muscle in ischemic heart disease, hypertension, and vasospastic disorders. In: Wester (ed) Electrolytes and the heart. Trans Medica Inc, NY (1983), pp 41–56Google Scholar
  12. 12.
    Commerford PJ, Lloyd EA (1984) Arrhythmias in patients with drug toxicity, electrolyte, and endocrine disturbances. Symp. on Cardiac Arrhythmias II. Med Clin North Am 68: 1051–1078Google Scholar
  13. 13.
    Cadell JL, Saier FL, Thomason CA (1975) Parenteral magnesium load test in postpartum American women. Am J Clin Nutr 28: 1099–1104Google Scholar
  14. 14.
    Cadell JL (1975) The magnesium load test. A design for infants. Clin Pediatr 14: 449–459Google Scholar
  15. 15.
    Iseri LT, Freed J, Bures AR (1975) Magnesium deficiency and cardiac disorders. Am J Med 58: 837–845Google Scholar
  16. 16.
    Winer BJ (1971) Statistical principles in experimental design, 2nd edn. McGraw Hill, New YorkGoogle Scholar
  17. 17.
    Geisser S, Greenhouse S (1958) An extension of Box's results on the use of F distribution in multivariate analysis. Ann Math Statist 29: 885–891Google Scholar
  18. 18.
    BMDP Statistical Software (1983) Dixon WJ (ed) University of California Press, Los AngelesGoogle Scholar
  19. 19.
    Welb S, Schade DS (1975) Hypomagnesemia as a cause of persistent hypokalemia. J Am Med Assoc 233: 23–24Google Scholar
  20. 20.
    Caplan M, Hastillo A, Mohakumar T, Hess ML (1984) Immunologic mechanisms in the atherosclerotic process. Cardiovasc Rev Rep 5: 713–721Google Scholar

Copyright information

© Springer-Verlag 1987

Authors and Affiliations

  • G. Cocco
    • 1
    • 2
  • H. U. Iselin
    • 3
  • C. Strozzi
    • 2
  • B. Cesana
    • 4
  • H. R. Baumeler
    • 1
  1. 1.Rehabilitationszentrum SolbadklinikRheinfeldenSwitzerland
  2. 2.Medical Clinics and Therapeutics, School of MedicineUniversity of FerraraFerraraItaly
  3. 3.Medical DepartmentRegionalspitalRheinfeldenSwitzerland
  4. 4.Institute of Medical SciencesUniversità degli studiMilanoItaly

Personalised recommendations